RRPV Solicitation Summary: Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services
SAM.GOV Due: May 30, 2025 at 05:00 PM UTC
In-Active Special Notice Source Url

Summary

The opportunity titled 'Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services' is a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA). This solicitation aims to engage contractors who can provide laboratory services focused on the immunogenicity of vaccines related to influenza and emerging infectious diseases. Businesses with expertise in laboratory services, particularly those specializing in immunoassays and vaccine research, are encouraged to bid on this opportunity. The work is critical for advancing public health responses to infectious diseases, and contractors should be prepared to demonstrate their capabilities in this specialized field.
Description

This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA), titled, “Central Influenza and

Entities
HAHSDO
Department of Health and Human Services
NAICS
541714
Set Aside
None
Point of Contact
Full Name Email Phone Type
Rebecca Harmon [email protected] primary
Attachments
  • 24-07-CentralIEIDLab_QandA_2025.05.05.xlsx
  • RRPV-RPP-24-07-CentralIEIDLab_Amd02.docx
  • RRPV-RPP-24-07-CentralIEIDLab_Amd03+posted.docx